Kissei Pharmaceutical Completes Restricted Share Disposition for Executives

TOKYO, Jul 23 (Pulse News Wire) – Kissei Pharmaceutical CO.,LTD. (4547.T) completed the repurchase of restricted shares for its directors and executive officers.

The transaction was approved during the board meeting held on June 23, 2026. Key details of the share repurchase include: - Payment completion date: July 23, 2026 - Type of shares: Ordinary shares - Number of shares repurchased: 19,794 - Price per share: ¥3,940 - Total amount paid: ¥78.0 million The repurchased shares are subject to transfer restrictions and were allocated to eight non-outsider directors and twelve executive officers.

For more detailed information, refer to the previous announcement dated June 23, 2026.